P&G Looks To “Transform” Categories, But Ackman Presses For Results
This article was originally published in The Tan Sheet
Executive Summary
CFO Jon Moeller says product launches will make “obsolete our existing categories and transform them in ways that create competitive advantage” for the firm. Activist investor Bill Ackman, however, says P&G is “vastly under-earning relative to its intrinsic earnings power.”
You may also be interested in...
If P&G Seeks OTC Sale, Pharma Buyers Might Line Up
P&G's activist investor Trian Fund Management is known for pressuring big companies to break up. The OTC business would likely have plenty of potential buyers.
P&G Could Lean Toward OTC Brand Sales With Activist Investor Influence
Analysts consider the potential for P&G splitting up or selling OTC or beauty care assets following CEO David Taylor's recent comments on possible moves with activist investor Trian. Analysts weigh in on the potential for sale or swap of brands and whether the moves would help.
P&G Could Lean Toward OTC Brand Sales With Activist Investor Influence
Analysts consider the potential for P&G splitting up or selling OTC or beauty care assets following CEO David Taylor's recent comments on possible moves with activist investor Trian. Analysts weigh in on the potential for sale or swap of brands and whether the moves would help.